{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-207530","form_type":"8-K","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2026-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.322466+00:00","generated_at":"2026-05-14T22:56:46.626480+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"FibroBiologics ups ATM offering to $7.5M; 71,830 shares sold to date","bullets":["Increased maximum aggregate offering price under ATM facility to $7.5 million.","71,830 shares of common stock sold to date under Sales Agreement with H.C. Wainwright & Co.","ATM offering uses existing S-3 shelf registration (effective Feb 10, 2025); prospectus supplement filed May 5, 2026.","Legal opinion and consent of Sichenzia Ross Ference Carmel LLP filed as exhibits."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-207530","json":"https://secwatch.observer/filing/0001193125-26-207530.json","markdown":"https://secwatch.observer/filing/0001193125-26-207530.md","text":"https://secwatch.observer/filing/0001193125-26-207530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526207530/0001193125-26-207530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526207530/fblg-20260505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T22:56:46.626480+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d09cabc6ba6ffff1938b78a7397a8519bca82e67","claim":"FibroBiologics, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC (effective 2026-05-01).","evidence_excerpt":"on May 1, 2026, FibroBiologics, Inc. (the “Company”) entered into that certain At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526207530/0001193125-26-207530-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Effective","value":"2026-05-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}